Aortic Stenosis

临床试验

Endothelial Progenitors in Aortic Stenosis: Association With Aortic Stenosis Progression and Severity

计划入组 200 人 · 首次发布于 2014 年 2 月 11 日

已完成

NCT00800800

Effects of Rosuvastatin on Aortic Stenosis Progression

计划入组 378 人 · 首次发布于 2008 年 12 月 2 日

招募中

NCT06129331

Aortic Stenosis and Cardiac Amyloidosis

计划入组 300 人 · 首次发布于 2023 年 11 月 13 日

药物

查看全部 108 →

olfactory mucosa-derived mesenchymal stem cells therapy (tracheal stenosis/laryngeal stenosis)

Small Molecule

Investigational

Limaprost

相关疾病：Ischemic Ulcers, Pain caused by Ischaemia，另有 1 项

C₂₂H₃₆O₅ · Rx

Small Molecule

Approved

Propranolol(Hemangeol, Hemangiol, Inderal, Innopran)

生产企业：Akrimax pharmaceuticals llc, Glaxosmithkline llc，另有 34 家

相关疾病：Akathisia caused by antipsychotic use, Angina Pectoris，另有 19 项

C₁₆H₂₁NO₂ · Rx

机构

查看全部 40 →

THUBRIKAR AORTIC VALVE INC

United States

Bolton Medical, Inc.

United States

Artivion

United States

资讯

查看全部 314 →

去年

FDA Approves First TAVR Therapy for Asymptomatic Severe Aortic Stenosis Patients

去年

Early Aortic Valve Intervention Fails to Show Benefit in Asymptomatic Patients with Severe Aortic Stenosis and Myocardial Fibrosis

去年

临床试验

Endothelial Progenitors in Aortic Stenosis: Association With Aortic Stenosis Progression and Severity

Effects of Rosuvastatin on Aortic Stenosis Progression

Aortic Stenosis and Cardiac Amyloidosis

药物

olfactory mucosa-derived mesenchymal stem cells therapy (tracheal stenosis/laryngeal stenosis)

Limaprost

Propranolol(Hemangeol, Hemangiol, Inderal, Innopran)

机构

THUBRIKAR AORTIC VALVE INC

Bolton Medical, Inc.

Artivion

资讯

FDA Approves First TAVR Therapy for Asymptomatic Severe Aortic Stenosis Patients

Early Aortic Valve Intervention Fails to Show Benefit in Asymptomatic Patients with Severe Aortic Stenosis and Myocardial Fibrosis

Aortic Valve Replacement Improves Outcomes in Cardiogenic Shock Due to Aortic Stenosis